Plasminogen Is Tethered with High Affinity to the Cell Surface by the Plasma Protein, Histidine-rich Glycoprotein*

Plasminogen has been implicated in extracellular matrix degradation by invading cells, but few high affinity cell surface receptors for the molecule have been identified. Previous studies have reported that the plasma protein, histidine-rich glycoprotein (HRG), interacts with plasminogen and cell surfaces, raising the possibility that HRG may immobilize plasminogen/plasmin to cell surfaces. Here we show, based on optical biosensor analyses, that immobilized HRG interacts with soluble plasminogen with high affinity and with an extremely slow dissociation rate. Furthermore, the HRG-plasminogen interaction is lysine-dissociable and involves predominately the amino-terminal domain of HRG, and the fifth kringle domain of plasminogen, but not the carboxyl-terminal lysine of HRG. HRG was also shown to tether plasminogen to cell surfaces, with this interaction being potentiated by elevated Zn2+ levels and low pH, conditions that prevail at sites of tissue injury, tumor growth, and angiogenesis. Based on these data we propose that HRG acts as a soluble adaptor molecule that binds to cells at sites of tissue injury, tumor growth, and angiogenesis, providing a high affinity receptor for tethering plasminogen to the cell surface and thereby enhancing the migratory potential of cells.

[1]  Brian A. Smith,et al.  Histidine-Rich Glycoprotein Binds to DNA and FcγRI and Potentiates the Ingestion of Apoptotic Cells by Macrophages1 , 2002, The Journal of Immunology.

[2]  J. Altin,et al.  Histidine-rich glycoprotein regulates the binding of monomeric IgG and immune complexes to monocytes. , 1999, International immunology.

[3]  J. Saurat,et al.  Differential protease expression by cutaneous squamous and basal cell carcinomas. , 1991, The Journal of clinical investigation.

[4]  F. Blasi Proteolysis, Cell Adhesion, Chemotaxis, and Invasiveness Are Regulated by the u-PA-u-PAR-PAI-1 System , 1999, Thrombosis and Haemostasis.

[5]  W. Morgan Interactions of the histidine-rich glycoprotein of serum with metals. , 1981, Biochemistry.

[6]  V. Schirrmacher,et al.  Sulfated glycosaminoglycans enhance tumor cell invasion in vitro by stimulating plasminogen activation. , 1998, Experimental cell research.

[7]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[8]  H. Chapman,et al.  Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. , 1997, Current opinion in cell biology.

[9]  J. Mimuro,et al.  Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin. , 1984, Thrombosis research.

[10]  J. Altin,et al.  Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes. , 1997, Biochemistry.

[11]  F. Castellino,et al.  Nonfibrinolytic functions of plasminogen. , 2000, Methods.

[12]  L. Orci,et al.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes , 1990, The Journal of cell biology.

[13]  S. L. Guthans,et al.  The interaction of zinc, nickel and cadmium with serum albumin and histidine-rich glycoprotein assessed by equilibrium dialysis and immunoadsorbent chromatography. , 1982, Archives of biochemistry and biophysics.

[14]  R. Gorodetsky,et al.  Platelet multielemental composition, lability, and subcellular localization , 1993, American journal of hematology.

[15]  A. Sappino,et al.  Plasminogen activation in human acute leukaemias , 1999, British journal of haematology.

[16]  W. T. Morgan,et al.  Acceleration of Plasminogen Activation by Tissue Plasminogen Activator on Surface-bound Histidine-proline-rich Glycoprotein* , 1997, The Journal of Biological Chemistry.

[17]  W. Morgan,et al.  Human serum histidine-rich glycoprotein. I. Interactions with heme, metal ions and organic ligands. , 1978, Biochimica et biophysica acta.

[18]  W. T. Morgan,et al.  Further characterization of the interaction of histidine-rich glycoprotein with heparin: evidence for the binding of two molecules of histidine-rich glycoprotein by high molecular weight heparin and for the involvement of histidine residues in heparin binding. , 1987, Biochemistry.

[19]  W. T. Morgan,et al.  Histidine-Proline-rich Glycoprotein as a Plasma pH Sensor , 1998, The Journal of Biological Chemistry.

[20]  J. Altin,et al.  Differential Binding of Histidine-rich Glycoprotein (HRG) to Human IgG Subclasses and IgG Molecules Containing κ and λ Light Chains* , 1999, The Journal of Biological Chemistry.

[21]  L. Leung Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. , 1986, The Journal of clinical investigation.

[22]  N. Chang,et al.  Regulation of complement functional efficiency by histidine-rich glycoprotein. , 1992, Blood.

[23]  E. Davie,et al.  Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. , 1986, Biochemistry.

[24]  D. Rylatt,et al.  Autorosette inhibition factor: isolation and properties of the human plasma protein. , 1981, European journal of biochemistry.

[25]  M. L. Hayes,et al.  Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation, and characterization. , 1979, The Journal of biological chemistry.

[26]  W. T. Morgan,et al.  The histidine-rich glycoprotein of serum has a domain rich in histidine, proline, and glycine that binds heme and metals. , 1985, Biochemistry.

[27]  H. Chapman,et al.  Macrophage fibrinolytic activity: Identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor , 1982, Cell.

[28]  M. L. Hayes,et al.  Carbohydrate of the human plasminogen variants. III. Structure of the O-glycosidically linked oligosaccharide unit. , 1979, The Journal of biological chemistry.

[29]  P. Hogg,et al.  Angiostatin Formation Involves Disulfide Bond Reduction and Proteolysis in Kringle 5 of Plasmin* , 1999, The Journal of Biological Chemistry.

[30]  M. Hoylaerts,et al.  Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma. , 1983, The Journal of biological chemistry.

[31]  E. Plow,et al.  Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. , 1989, Biochemistry.

[32]  D. Belin,et al.  The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.

[33]  J. Hoover-Plow,et al.  The cell biology of the plasminogen system , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  K. Hajjar,et al.  A mediator of cell surface-specific plasmin generation. , 2006, Annals of the New York Academy of Sciences.

[35]  M. L. Hayes,et al.  Carbohydrate of the human plasminogen variants. II. Structure of the asparagine-linked oligosaccharide unit. , 1979, The Journal of biological chemistry.

[36]  M. Hoylaerts,et al.  Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. , 1980, The Journal of biological chemistry.

[37]  M. Hulett,et al.  Histidine-rich Glycoprotein Binds to Cell-surface Heparan Sulfate via Its N-terminal Domain following Zn2+ Chelation* , 2004, Journal of Biological Chemistry.

[38]  W. T. Morgan,et al.  Interaction of histidine-proline-rich glycoprotein with plasminogen: effect of ligands, pH, ionic strength, and chemical modification. , 1995, Biochemistry.

[39]  D. Collen Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. , 2001, Hematology. American Society of Hematology. Education Program.

[40]  H. Lijnen Elements of the Fibrinolytic System , 2001, Annals of the New York Academy of Sciences.

[41]  X C Zhang,et al.  Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues. , 2000, Trends in biochemical sciences.

[42]  N. Aoki,et al.  Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. , 1976, Journal of Biological Chemistry.

[43]  D. Collen The Plasminogen (Fibrinolytic) System , 1999, Thrombosis and Haemostasis.

[44]  D. Walz,et al.  Binding of Thrombospondin to Immobilized Ligands: Specific Interaction with Fibrinogen, Plasminogen, Histidine-Rich Glycoprotein, and Fibronectin , 1987, Seminars in thrombosis and hemostasis.

[45]  K. Brown Effect of infections on plasma zinc concentration and implications for zinc status assessment in low-income countries. , 1998, The American journal of clinical nutrition.

[46]  B. Wiman Affinity-chromatographic purification of human α2-antiplasmin , 1980 .

[47]  L. Levitt,et al.  Interaction of histidine-rich glycoprotein with human T lymphocytes. , 1989, The Journal of biological chemistry.

[48]  W. T. Morgan,et al.  Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding. , 1987, The Journal of biological chemistry.

[49]  R. Ruddon Biological markers of neoplasia : basic and applied aspects , 1978 .

[50]  Timo K. Korhonen,et al.  Plasminogen activation in degradation and penetration of extracellular matrices and basement membranes by invasive bacteria. , 2000, Methods.

[51]  E. Rickli,et al.  A new method of isolation and some properties of the heavy chain of human plasmin. , 1975, European journal of biochemistry.

[52]  Jordi Félez,et al.  Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. , 1991, Biochemistry.

[53]  R. Hill,et al.  The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation. , 1975, The Journal of biological chemistry.